Results 151 to 160 of about 5,411,335 (287)
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Porous hydrogels, possessing both high mechanical strength and high permeability, are sought after in energy storage, soft robotics, solar vapor generation, and tissue engineering.
Mengze Lu (14262906) +10 more
core +1 more source
α-Synuclein aggregation landscape from phase separation to neurotoxic intermediates. [PDF]
Arino S, Fusco G, De Simone A.
europepmc +1 more source
Spatial biology in cancer epigenetics
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source
The Effect of Protein Tagging on Aggregation and Phase Separation. [PDF]
Saito H, Sugase K.
europepmc +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
A pH-Responsive fluorescence lifetime probe reveals GOT1 phase separation in cellular anti-senescence. [PDF]
Chen Z +8 more
europepmc +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Putting the Squeeze on Phase Separation
Carla Fernández-Rico +4 more
doaj +1 more source
Diverging Liquid-Liquid Phase Separation Behavior of Different Recombinant Major Ampullate Spidroins. [PDF]
Schiller T, Hayashi C, Scheibel TR.
europepmc +1 more source

